MenuMENU

Press Releases > JMT Focuses on Use of Chelation for Metal Poisoning in December Issue - December 3, 2013

JMT Focuses on Use of Chelation for Metal Poisoning in December Issue - December 3, 2013

posted on 5:42 AM, June 26, 2014
Click here for a .pdf of this press release.
 
PRWeb ebooks - Another online visibility tool from PRWeb
 
The December issue of the Journal of Medical Toxicology focuses on the use of chelating drugs
for treatment of poisoning due to metals such as mercury and lead. Many of the articles are
adapted from presentations delivered at the conference ‘Use & Misuse of Metal Chelation
Therapy’ held at the CDC in Atlanta in 2012 and supported by the CDC’s Agency for Toxic
Substances and Disease Registry (ATSDR) Cooperative Agreement between ACMT and
ATSDR.
 
Phoenix, Arizona (PRWEB) December 03, 2013 -- The December issue of the Journal of Medical Toxicology
(JMT), the official journal of the American College of Medical Toxicology (ACMT), is a special issue featuring
the most up-to-date scientific information on chelation therapy for human poisoning from various metals,
including lead, mercury, and arsenic. According to Charles McKay, MD, the section chief for the Division of
Medical Toxicology at Hartford Hospital and the guest editor of the December issue, the articles will “provide
guidance to the public and clinicians considering the diagnosis and treatment of metal poisoning. These
documents provide support for the ‘Choosing Wisely’ recommendations from ACMT to avoid commonly used,
rarely necessary, and potentially harmful tests or procedures to avoid misdiagnosis and over-treatment of
patients unlikely to have metal poisoning. In addition, the principles developed from these documents can be
used to evaluate inappropriate medical practice.”
 
Many of the articles in this issue are adapted from presentations delivered by highly-regarded national experts
at the “Use & Misuse of Metal Chelation Therapy” conference held at the Centers for Disease Control in
Atlanta, GA in 2012. They review the importance of proper patient evaluation, historic and current use of
laboratory testing for metal toxicity, and important scientific information on the risks and benefits of using
metal chelators in the treatment of metal poisoning. Myths and misconceptions about the diagnosis of metal
poisoning and safe treatment are addressed in several of the papers. New data is presented on the potential risks
of administering succimer or other metal chelating agents to children who do not have elevated tissue lead
levels. This issue also includes an article concerning the clinical consequences of cobalt exposure in the setting
of prosthetic metal-on-metal hip implants and a series of case presentations featuring real patients. Front-line
medical providers evaluating patients with concerns about metal exposure will find these articles particularly
helpful.
 
ACMT is a professional, non-profit association of physicians with recognized expertise in medical toxicology.
The College is dedicated to advancing the science and practice of medical toxicology through a variety of
activities.